Belite Bio Net Income

Belite Bio (BLTE) currently reports a net income of $-100M as of June 2026. That compares with $-49M in the prior-year period — down 107.3% year over year. That is below the sector sector average of $90M. Use the charts on this page to explore Belite Bio's net income history and peer comparisons.

Belite Bio's net income decreased from $-49M to $-100M — a 107.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Belite Bio's net income of $-100M is lower than the its sector sector average of $90M. That is roughly 213.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Belite Bio reported $-100M in net income as of June 2026. That compares with $-49M in the prior-year period — down 107.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-100M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $90M. From there, open related valuation or income-statement pages for Belite Bio, and consider following BLTE for alerts when major investors trade the stock.